Caxton Associates (New York)’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,612
Closed -$207K 500
2024
Q3
$207K Sell
8,612
-8,423
-49% -$193K 0.01% 483
2024
Q2
$339K Buy
17,035
+2,034
+14% +$39.6K 0.01% 391
2024
Q1
$299K Sell
15,001
-16,418
-52% -$317K 0.02% 385
2023
Q4
$705K Buy
31,419
+7,147
+29% +$148K 0.04% 272
2023
Q3
$491K Buy
+24,272
New +$550K 0.07% 249
2023
Q2
Sell
-10,633
Closed -$316K 497
2023
Q1
$316K Sell
10,633
-2,475
-19% -$71.9K 0.05% 343
2022
Q4
$355K Buy
13,108
+2,048
+19% +$50.1K 0.03% 300
2022
Q3
$241K Buy
+11,060
New +$289K 0.04% 366

Other funds holding AVNS